Chih‐Long Chang

1.2k total citations
42 papers, 523 citations indexed

About

Chih‐Long Chang is a scholar working on Oncology, Surgery and Obstetrics and Gynecology. According to data from OpenAlex, Chih‐Long Chang has authored 42 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Surgery and 11 papers in Obstetrics and Gynecology. Recurrent topics in Chih‐Long Chang's work include Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (11 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Chih‐Long Chang is often cited by papers focused on Endometrial and Cervical Cancer Treatments (11 papers), Ovarian cancer diagnosis and treatment (11 papers) and Intraperitoneal and Appendiceal Malignancies (7 papers). Chih‐Long Chang collaborates with scholars based in Taiwan, South Korea and China. Chih‐Long Chang's co-authors include Ya‐Ting Jan, Jie Lee, Meng‐Hao Wu, Jhen‐Bin Lin, Fang‐Ju Sun, Yu-Jen Chen, Yu‐Jen Chen, Yun-Ting Hsu, Yuh‐Cheng Yang and Jen‐Ruei Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Chih‐Long Chang

39 papers receiving 513 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chih‐Long Chang Taiwan 14 157 156 136 117 92 42 523
Breton Roussel United States 8 82 0.5× 81 0.5× 32 0.2× 74 0.6× 62 0.7× 21 327
Kristen K. Rumer United States 9 163 1.0× 30 0.2× 183 1.3× 71 0.6× 119 1.3× 25 534
Bo Grønlund Denmark 11 118 0.8× 27 0.2× 119 0.9× 159 1.4× 77 0.8× 25 394
Hiroki Ishibashi Japan 13 137 0.9× 24 0.2× 131 1.0× 332 2.8× 108 1.2× 70 667
Frederick M. Schnell United States 8 199 1.3× 55 0.4× 60 0.4× 192 1.6× 51 0.6× 17 481
Yingyi Zhang China 10 114 0.7× 27 0.2× 29 0.2× 58 0.5× 117 1.3× 21 448
Erdem Çubukçu Türkiye 12 253 1.6× 46 0.3× 13 0.1× 37 0.3× 106 1.2× 51 481
Christine Bekos Austria 14 108 0.7× 32 0.2× 26 0.2× 82 0.7× 108 1.2× 36 418
Ichiro Kasahara Japan 12 63 0.4× 39 0.3× 49 0.4× 128 1.1× 71 0.8× 19 362
Κonstantinos Romanidis Greece 13 237 1.5× 33 0.2× 17 0.1× 175 1.5× 113 1.2× 55 594

Countries citing papers authored by Chih‐Long Chang

Since Specialization
Citations

This map shows the geographic impact of Chih‐Long Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chih‐Long Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chih‐Long Chang more than expected).

Fields of papers citing papers by Chih‐Long Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chih‐Long Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chih‐Long Chang. The network helps show where Chih‐Long Chang may publish in the future.

Co-authorship network of co-authors of Chih‐Long Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Chih‐Long Chang. A scholar is included among the top collaborators of Chih‐Long Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chih‐Long Chang. Chih‐Long Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jie, et al.. (2025). Whole-uterine versus individualized-uterine radiotherapy in locally advanced cervical cancer: clinical outcome and toxicity. International Journal of Gynecological Cancer. 35(5). 101817–101817.
2.
3.
Tsai, Ya-Chea, et al.. (2024). STAT1-Deficient HPV E6/E7-Associated Cancers Maintain Host Immunocompetency against Therapeutic Intervention. Vaccines. 12(4). 430–430. 1 indexed citations
4.
Chang, Chih‐Long, et al.. (2023). Association of malignant ascites with systemic inflammation and muscle loss after treatment in advanced‐stage ovarian cancer. Journal of Cachexia Sarcopenia and Muscle. 14(5). 2114–2125. 9 indexed citations
5.
Chang, Chih‐Long, et al.. (2023). Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer. Journal of Cachexia Sarcopenia and Muscle. 14(5). 2044–2053. 24 indexed citations
6.
7.
Tse, Ka Yu, Kimio Ushijima, Ai Ling Tan, et al.. (2023). A questionnaire study on disparity of cervical cancer prevention programs in Asia‐Oceania. Journal of obstetrics and gynaecology research. 49(4). 1230–1243. 3 indexed citations
8.
Chen, Chien‐Chin, Chyong‐Huey Lai, Chih‐Long Chang, et al.. (2023). Managing the transition in cervical screening methods for Taiwan: Policy recommendations and perspectives. Journal of the Formosan Medical Association. 122(11). 1213–1218. 3 indexed citations
9.
Chou, Hung‐Hsueh, Sián Fereday, Anna DeFazio, et al.. (2022). Contrasting clinical characteristics and treatment patterns in women with newly diagnosed advanced-stage epithelial ovarian cancer in Australia, South Korea and Taiwan. Journal of Gynecologic Oncology. 34(1). e3–e3. 2 indexed citations
10.
Lee, Jie, Jhen‐Bin Lin, Chih‐Long Chang, et al.. (2022). Optimal prophylactic para-aortic radiotherapy in locally advanced cervical cancer: anatomy-based versus margin-based delineation. International Journal of Gynecological Cancer. 32(5). 606–612. 4 indexed citations
11.
Lee, Jie, Jhen‐Bin Lin, Meng‐Hao Wu, et al.. (2021). Association of bowel radiation dose-volume with skeletal muscle loss during pelvic intensity-modulated radiotherapy in cervical cancer. Supportive Care in Cancer. 29(9). 5497–5505. 9 indexed citations
12.
13.
Hsu, Yun-Ting, et al.. (2019). Less circulating mucosal-associated invariant T cells in patients with cervical cancer. Taiwanese Journal of Obstetrics and Gynecology. 58(1). 117–121. 18 indexed citations
14.
Hsu, Yun-Ting, et al.. (2019). Clinical significance of c-Met and phospho-c-Met (Tyr1234/1235) in ovarian cancer. Taiwanese Journal of Obstetrics and Gynecology. 58(1). 105–110. 7 indexed citations
15.
Lee, Jie, Jhen‐Bin Lin, Fang‐Ju Sun, et al.. (2017). Safety and efficacy of semiextended field intensity-modulated radiation therapy and concurrent cisplatin in locally advanced cervical cancer patients. Medicine. 96(10). e6158–e6158. 21 indexed citations
16.
Jan, Ya‐Ting, et al.. (2016). The air matters – sleeve air cavity as a marker guiding image-guided helical tomotherapy to target cervical cancer. Journal of Contemporary Brachytherapy. 1(1). 82–87. 4 indexed citations
17.
Yang, Yuh‐Cheng, et al.. (2016). Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer. Taiwanese Journal of Obstetrics and Gynecology. 55(3). 405–409. 9 indexed citations
18.
Chen, Tze-Chien, Meng‐Hao Wu, Jen‐Ruei Chen, et al.. (2012). Role of Transperitoneal Laparoscopic Para-aortic Lymph Node Dissection for the Treatment of Elderly Patients with Locally Advanced Squamous Cell Carcinoma of the Uterine Cervix. SHILAP Revista de lepidopterología. 6(3). 206–210.
19.
Chang, Chih‐Long, et al.. (2012). Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance. Taiwanese Journal of Obstetrics and Gynecology. 51(3). 336–341. 13 indexed citations
20.
Chen, Chih‐Ping, Yi‐Ning Su, Shin‐Yu Lin, et al.. (2011). Rapid aneuploidy diagnosis by multiplex ligation-dependent probe amplification and array comparative genomic hybridization in pregnancy with major congenital malformations. Taiwanese Journal of Obstetrics and Gynecology. 50(1). 85–94. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Breton Roussel Breakdown of academic impact, for papers by Kristen K. Rumer Breakdown of academic impact, for papers by Bo Grønlund Breakdown of academic impact, for papers by Hiroki Ishibashi Breakdown of academic impact, for papers by Frederick M. Schnell Breakdown of academic impact, for papers by Yingyi Zhang Breakdown of academic impact, for papers by Erdem Çubukçu Breakdown of academic impact, for papers by Christine Bekos Breakdown of academic impact, for papers by Ichiro Kasahara Breakdown of academic impact, for papers by Κonstantinos Romanidis
Rankless by CCL
2026